CPT® Code 0696T

Body surface-activation mapping of pacemaker or pacing cardioverter-defibrillator lead(s) to optimize electrical synchrony, cardiac resynchronization therapy device, including connection, recording, disconnection, review, and report; at time of follow-up interrogation or programming device evaluation

The CPT® Code 0696T refers to a specialized procedure known as body surface-activation mapping, which is utilized in the context of optimizing the performance of pacemakers or pacing cardioverter-defibrillator leads. This procedure is particularly relevant for patients undergoing cardiac resynchronization therapy (CRT). The primary goal of body surface-activation mapping is to enhance electrical synchrony within the heart, thereby improving the overall effectiveness of the CRT device. This is achieved through individualized programming of the device, which aims to reduce electrical dyssynchrony that can adversely affect cardiac function.

During the procedure, a body surface-activation mapping system employs a network of 64 to 120 electrodes strategically placed on the patient's torso. This extensive coverage surpasses that of a standard 12-lead electrocardiogram (ECG), allowing for a more comprehensive recording and analysis of the heart's electrocardiac activity. The electrodes are typically integrated into a vest that is worn by the patient, with a conducting gel applied to ensure optimal contact with the skin. The data collected from this mapping process provides critical insights into the distribution of electrical potentials, specifically the QRS, ST, and T waveforms, across the body surface.

Activation times are calculated based on the interval from the onset of the QRS complex to the steepest negative slope, which is essential for assessing the timing of electrical activation in the heart. The resulting body surface maps illustrate activation times, which are instrumental in evaluating and addressing electrical dyssynchrony. Key parameters derived from this mapping, such as the standard deviation of activation times (SDAT) and the average left thorax activation time (LVAT), are utilized to refine the placement of left ventricular leads and to optimize the programming of both left ventricular and biventricular pacing settings. Notably, these BSAM-based calculations can lead to significant improvements in ventricular activation time, with enhancements of up to 46% compared to conventional pacing settings. This procedure is distinct from the initial mapping performed at the time of CRT device implantation or replacement, which is coded under CPT® Code 0695T, as 0696T specifically pertains to follow-up evaluations and programming adjustments for devices already in place.